Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Nature Communications|March 29, 2017
Inhibiting the system xC-/glutathione axis selectively targets cancers with mutant-p53 accumulationDavid S Liu, Cuong P Duong, Sue Haupt, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 1, 2015
Ubiquitous expression of the Pik3caH1047R mutation promotes hypoglycemia, hypoinsulinemia, and organomegalyKathryn M Kinross, Karen G Montgomery, Salvatore P Mangiafico, et al.
Scientific Reports|February 6, 2019
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapyEmily J Lelliott, Carleen Cullinane, Claire A Martin, et al.
ACS Nano|February 6, 2025
Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor PenetrationDaniel Yuen, Orlagh M Feeney, Leo Noi, et al.
Blood|February 14, 2013
Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomasJake Shortt, Benjamin P Martin, Andrea Newbold, et al.
The Journal of Clinical Investigation|November 16, 2013
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formationMaya Kansara, Huei San Leong, Dan Mei Lin, et al.
International Journal of Cancer|December 16, 2017
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistanceClaire A Martin, Carleen Cullinane, Laura Kirby, et al.
European Journal of Clinical Pharmacology|September 4, 2021
Evaluation of pharmacogenomics and hepatic nuclear imaging-related covariates by population pharmacokinetic models of irinotecan and its metabolitesZheng Liu, Jennifer H Martin, Winston Liauw, et al.
Cancer Discovery|October 23, 2015
Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven LymphomaJennifer R Devlin, Katherine M Hannan, Nadine Hein, et al.
Cancer Immunology Research|December 11, 2020
Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in MelanomaEmily J Lelliott, Stefano Mangiola, Kelly M Ramsbottom, et al.
Pageof 11